One-year data suggest allogeneic stem cell-derived islet-cell therapy could become a future option for those with type 1 ...

A single infusion of zimislecel, an investigational stem cell-based therapy, restored physiologic islet function and conferred improved outcomes and insulin independence at 1 year in a small study of ...

Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes.

First Canadian to receive procedure says she would do it ‘a million times over’ compared with previous work to keep blood ...

Presentation to highlight updated six-month clinical results of a hypoimmune-modified primary pancreatic islet cell therapy for patients with type 1 diabetesSEATTLE, June 09, 2025 (GLOBE NEWSWIRE) -- ...

Greenwood, Coates and Burton’s company Beta Cell Technologies are committed to finding long-term therapeutic solutions for ...

The procedure is used exclusively for patients with Type 1 diabetes. It is not considered a treatment for Type 2 diabetes, ...

Over 500 million people worldwide suffer from diabetes—a disease that contributes to major complications such as stroke, ...